Investigating the Molecular Basis of the Aggregation Propensity of the Pathological D76N Mutant of Beta-2 Microglobulin: Role of the Denatured State.
denatured state
protein aggregation
protein stability
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Jan 2019
18 Jan 2019
Historique:
received:
27
11
2018
revised:
09
01
2019
accepted:
11
01
2019
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
2
5
2019
Statut:
epublish
Résumé
Beta-2 microglobulin (β2m) is a protein responsible for a pathologic condition, known as dialysis-related amyloidosis (DRA), caused by its aggregation and subsequent amyloid formation. A naturally occurring mutation of β2m, D76N, presents a higher amyloidogenic propensity compared to the wild type counterpart. Since the three-dimensional structure of the protein is essentially unaffected by the mutation, the increased aggregation propensity of D76N has been generally ascribed to its lower thermodynamic stability and increased dynamics. In this study we compare the equilibrium unfolding and the aggregation propensity of wild type β2m and D76N variant at different experimental conditions. Our data revealed a surprising effect of the D76N mutation in the residual structure of the denatured state, which appears less compact than that of the wild type protein. A careful investigation of the structural malleability of the denatured state of wild type β2m and D76N pinpoint a clear role of the denatured state in triggering the amyloidogenic propensity of the protein. The experimental results are discussed in the light of the previous work on β2m and its role in disease.
Identifiants
pubmed: 30669253
pii: ijms20020396
doi: 10.3390/ijms20020396
pmc: PMC6359115
pii:
doi:
Substances chimiques
Protein Aggregates
0
Recombinant Proteins
0
beta 2-Microglobulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 18701
Organisme : Fondazione Cariplo
ID : 2016-0489
Références
Biochemistry. 2000 Aug 1;39(30):8735-46
pubmed: 10913285
Biophys J. 2012 Apr 4;102(7):1676-84
pubmed: 22500768
J Biol Chem. 2011 Feb 4;286(5):3863-72
pubmed: 21118804
Nat Commun. 2018 Oct 30;9(1):4517
pubmed: 30375379
J Biol Chem. 2015 Apr 17;290(16):9951-8
pubmed: 25750126
J Clin Invest. 1985 Dec;76(6):2425-9
pubmed: 3908488
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96
pubmed: 24854788
J Biol Chem. 2014 Feb 7;289(6):3318-27
pubmed: 24338476
Nature. 2005 Oct 13;437(7061):1053-6
pubmed: 16222301
N Engl J Med. 2012 Jun 14;366(24):2276-83
pubmed: 22693999
Sci Rep. 2016 May 06;6:25559
pubmed: 27150430
J Mol Biol. 2008 May 9;378(4):887-97
pubmed: 18395224
Crit Rev Biochem Mol Biol. 2005 Jul-Aug;40(4):181-9
pubmed: 16126485
Annu Rev Biochem. 2017 Jun 20;86:27-68
pubmed: 28498720
Nat Commun. 2019 Mar 7;10(1):1104
pubmed: 30846696
Curr Opin Struct Biol. 2007 Feb;17(1):3-14
pubmed: 17250999
Biochemistry. 1996 Feb 27;35(8):2738-49
pubmed: 8611580
J Am Chem Soc. 2010 Apr 28;132(16):5556-7
pubmed: 20356307
PLoS One. 2015 Dec 01;10(12):e0144061
pubmed: 26625273
Protein Sci. 1995 Oct;4(10):2138-48
pubmed: 8535251
Nat Commun. 2019 Mar 20;10(1):1269
pubmed: 30894521
Science. 2001 Jul 20;293(5529):487-9
pubmed: 11463915
ACS Chem Biol. 2017 Jun 16;12(6):1683-1690
pubmed: 28459531
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17772-6
pubmed: 22652570
J Am Chem Soc. 2011 Sep 14;133(36):14160-3
pubmed: 21650202
Annu Rev Biochem. 2006;75:333-66
pubmed: 16756495
J Mol Biol. 2003 Jul 25;330(5):943-54
pubmed: 12860118
Nat Struct Biol. 2001 Aug;8(8):659-60
pubmed: 11473247
Amyloid. 2007 Sep;14(3):179-83
pubmed: 17701465
Nat Commun. 2018 Apr 25;9(1):1658
pubmed: 29695721
Biochem Biophys Res Commun. 1985 Jun 28;129(3):701-6
pubmed: 3893430